Business

Despite surging commodity prices in China - which must be real and represent demand growth and price increases, right? - Aussie core inflation slowed to the weakest on record as headline prices unexpectedly fell last quarter (CPI -0.2%). RBA Rate-cut odds tripled instantly sending AUD down over 1.2% (its biggest drop in 2 months). Perhaps, just perhaps, that collossal credit injection in Q1 via China did not make it into the AsiaPac economy after all and merely fueled a speculative frenzy in commodities that merely "looks" like a recovery?

This afternoon Jeffrey Gundlach held one of his periodic interviews with Reuters' Jenna Ablan in which he said that the selloff in Treasuries is over and that investors looking to purchase Treasuries in the wake of the bond market's sell-off - if one can call a move in the 10Y to 1.91% a selloff - are making a prudent move. "I think it is a reasonable strategy to start legging into the Treasury market."

Via HardAssetsAlliance.com,

Apple spent about five years developing the iPhone, which has changed the smartphone market forever. Until the release, however, nobody could imagine what impact the iPhone would have on the market.

And most consumers didn’t know about it at all.

The same thing is happening with China and gold right now. The gold market will soon be very different than from what we see today - largely due to the current developments in China.

Almost two weeks ago, On April 14, we reported the striking news that DB has decided to "turn" against the precious metals manipulation cartel by first settling long-running silver and gold price fixing lawsuits which in addition to "valuable monetary consideration" would expose the other banks' rigging after DB also "agreed to provide cooperation to plaintiffs, including the production of instant messages, and other electronic communications, as part of the settlement."

First it was the blow up of hedge fund darling Valeant that crushed countless funds who were long the name.

Then, one month ago after the collapse of the Allergan-Pfizer deal, we showed (one of the reasons) why the hedge fund world continued to underperform the broader market: Allergan was one of the most widely held hedge fund stocks.